A study from Johns Hopkins Medicine reveals that older adults with weakened immune systems, such as organ transplant recipients, may not produce sufficient protective antibodies against respiratory syncytial virus after vaccination.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
